NAI500 is excited to introduce three companies on our growing online investor platform, www.NAI500.com. Visit their profiles below to learn what opportunities they bring.
The Yield Growth Corp (CSE:BOSS)
Yield Growth developments and acquires wellness products infused with hemp root oil and sell them to consumers and licenses them to businesses under Urban JuveTM, a modern, Ayurveda-inspired wellness brand. Urban JuveTM is focused on the nourishment, rejuvenation and transformation of the body from the inside out. Urban JuveTM inspires wellness-conscious consumers to #findyourjuve with personalized and carefully crafted, hemp root oil infused cosmeceutical and therapeutic products. Yield Growth also offer business development services to new businesses.
Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.
Beleave Inc (CSEBE)
Beleave is a vertically-integrated Canadian cannabis company headquartered in Oakville, Ontario, that operates streamlined facilities throughout Canada to cultivate high-quality cannabis flower, oil, and extracts with funded capacity in excess of 150,000 kg per year. Fully-licensed to cultivate and sell medical and recreational cannabis, Beleave is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. Beleave is currently developing new product lines for October 2019 as the recreational market is expected to allow for food and beverage-based cannabis products.
Production Capacity (Total production capacity 1,731,500 SQ FT at 2020)
Product Development
Sales and Distribution
House of Brands
Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.
Alzex Biomedical Group
Alzex is a collaboration of researchers, scientists, and investors that have developed and patented precision therapeutics for the treatment of Alzheimer’s and other neurological diseases. Their North American headquarters is located in Vancouver B.C with their laboratories located in France (Normandy).
Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.